Simplex Trading, LLC Sana Biotechnology, Inc. Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$5.23 - $10.44 $35,417 - $70,699	6,772 Added 14.56%	53,288 $290,000
Q1 2024 Apr 25, 2024	BUY	$4.2 - $11.27 $119,431 - $320,473	28,436 Added 157.28%	46,516 $465,000
Q4 2023 Feb 02, 2024	BUY	$2.8 - $4.55 $30,556 - $49,654	10,913 Added 152.27%	18,080 $73,000
Q3 2023 Nov 01, 2023	BUY	$3.77 - $6.23 $27,019 - $44,650	7,167 New	7,167 $27,000
Q4 2022 Feb 02, 2023	SELL	$3.19 - $6.46 $4,861 - $9,845	-1,524 Reduced 49.22%	1,572 $6,000
Q3 2022 Nov 04, 2022	BUY	$5.58 - $9.04 $13,386 - $21,686	2,399 Added 344.19%	3,096 $18,000
Q2 2022 Aug 03, 2022	SELL	$4.12 - $9.35 $9,760 - $22,150	-2,369 Reduced 77.27%	697 $4,000
Q1 2022 May 02, 2022	BUY	$5.24 - $15.58 $14,022 - $41,692	2,676 Added 686.15%	3,066 $25,000
Q4 2021 Feb 23, 2022	SELL	$15.18 - $23.15 $5,495 - $8,380	-362 Reduced 48.14%	390 $6,000
Q3 2021 Oct 28, 2021	SELL	$16.29 - $25.88 $1,629 - $2,588	-100 Reduced 11.74%	752 $14,000
Q2 2021 Aug 12, 2021	BUY	$16.65 - $32.14 $14,185 - $27,383	852 New	852 $16,000

174

121M

1.87M

1.48M

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $314M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.